✦ LIBER ✦

Discovery & development of selective M3 antagonists for clinical use

✍ Scribed by V.A. Alabaster

Book ID: 117174913
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 543 KB
Volume: 60
Category: Article
ISSN: 0024-3205
DOI: 10.1016/s0024-3205(97)00047-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery and Development of Selective M

Discovery and Development of Selective M3 Antagonists for Clinical Use

✍ Alabaster, V.A. 📂 Article 📅 1998 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 225 KB

Pre-clinical and clinical pharmacology o

Pre-clinical and clinical pharmacology of selective muscarinic M3 receptor antagonists

✍ R.M Wallis 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 526 KB

Chiesi/SALVAT development agreements for

Chiesi/SALVAT development agreements for muscarinic M3 receptor antagonists

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Discovery of SB-705498: A Potent, Select

Discovery of SB-705498: A Potent, Selective and Orally Bioavailable TRPV1 Antagonist Suitable for Clinical Development.

✍ Harshad K. Rami; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 10 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

Discovery of SB-705498: A potent, select

Discovery of SB-705498: A potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development

✍ Harshad K. Rami; Mervyn Thompson; Geoffrey Stemp; Steve Fell; Jeffrey C. Jerman; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 290 KB

Discovery of Diaryl Imidazolidin-2-one D

Discovery of Diaryl Imidazolidin-2-one Derivatives, a Novel Class of Muscarinic M3 Selective Antagonists (Part 2)

✍ Peretto, Ilaria; Fossati, Claudia; Giardina, Giuseppe A. M.; Giardini, Alessandr 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 112 KB